Topical Sirolimus to Treat Tuberous Sclerosis Complex (TSC)

被引：12

作者：

Darling, Thomas N. ^{[1
]}

机构：

[1] Uniformed Serv Univ Hlth Sci, Dept Dermatol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA

来源：

JAMA DERMATOLOGY | 2018年 / 154卷 / 07期

关键词：

LONG-TERM TREATMENT; RAPAMYCIN; SKIN; INHIBITORS; EFFICACY;

D O I：

10.1001/jamadermatol.2018.0465

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：761 / 762

页数：2

共 15 条

[1] Macrolactam immunomodulators for topical treatment of inflammatory skin diseases [J].

Bornhövd, E ;

Burgdorf, WHC ;

Wollenberg, A .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (05) :736-743

[2] Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin [J].

Dickinson, Sally E. ;

Janda, Jaroslav ;

Criswell, Jane ;

Blohm-Mangone, Karen ;

Olson, Erik R. ;

Liu, Zhonglin ;

Barber, Christy ;

Petricoin, Emanuel F., III ;

Calvert, Valerie S. ;

Einspahr, Janine ;

Dickinson, Jesse E. ;

Stratton, Steven P. ;

Curiel-Lewandrowski, Clara ;

Saboda, Kathylynn ;

Hu, Chengcheng ;

Bode, Ann M. ;

Dong, Zigang ;

Alberts, David S. ;

Bowden, G. Timothy .

CANCER PREVENTION RESEARCH, 2016, 9 (03) :215-224

[3] mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders [J].

Franz, David N. ;

Capal, Jamie K. .

ORPHANET JOURNAL OF RARE DISEASES, 2017, 12

[4]

Haemel AK, 2010, ARCH DERMATOL, V146, P715, DOI 10.1001/archdermatol.2010.125

[5] Efficacy of Topical Sirolimus (Rapamycin) for the Treatment of Microcystic Lymphatic Malformations [J].

Ivars, Marta ;

Redondo, Pedro .

JAMA DERMATOLOGY, 2017, 153 (01) :103-105

[6] Topical Use of Mammalian Target of Rapamycin (mTOR) Inhibitors in Tuberous Sclerosis Complex-A Comprehensive Review of the Literature [J].

Jozwiak, Sergiusz ;

Sadowski, Krzysztof ;

Kotulska, Katarzyna ;

Schwartz, Robert A. .

PEDIATRIC NEUROLOGY, 2016, 61 :21-27

[7] Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex The TREATMENT Randomized Clinical Trial [J].

Koenig, Mary Kay ;

Bell, Cynthia S. ;

Hebert, Adelaide A. ;

Roberson, Joan ;

Samuels, Joshua A. ;

Slopis, John M. ;

Tate, Patti ;

Northrup, Hope .

JAMA DERMATOLOGY, 2018, 154 (07) :773-780

[8] Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients [J].

Malissen, Nausicaa ;

Vergely, Laurence ;

Simon, Marguerite ;

Roubertie, Agathe ;

Malinge, Marie-Claire ;

Bessis, Didier .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (03) :464-+

[9] Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus [J].

Nathan, Neera ;

Wang, Ji-an ;

Li, Shaowei ;

Cowen, Edward W. ;

Haughey, Mary ;

Moss, Joel ;

Darling, Thomas N. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (05) :802-808

[10] Applying the Lessons of Tuberous Sclerosis: The 2015 Hower Award Lecture [J].

Roach, E. Steve .

PEDIATRIC NEUROLOGY, 2016, 63 :6-22

← 1 2 →